Screening and Evaluation of Novel Compounds against Hepatitis B Virus Polymerase Using Highly Purified Reverse Transcriptase Domain
Hepatitis B virus (HBV) polymerase seems to be very hard to express and purify sufficiently, which has long hampered the generation of anti-HBV drugs based on the nature of the polymerase. To date, there has been no useful system developed for drug screening against HBV polymerase. In this study, we...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2020-07-01
|
| Col·lecció: | Viruses |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/1999-4915/12/8/840 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|